Related references
Note: Only part of the references are listed.Proton pump inhibitors use and dementia risk: a meta-analysis of cohort studies
Yun Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study
Yao-Tung Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients
Ya Qi Song et al.
PLOS ONE (2019)
Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study
Shelly L. Gray et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users
In Cheol Hwang et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline
Mette Wod et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013
Sun-Kyeong Park et al.
DRUG SAFETY (2018)
Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis
Patrick Imfeld et al.
DRUG SAFETY (2018)
Association Between Proton Pump Inhibitor Use and Cognitive Function in Women
Paul Lochhead et al.
GASTROENTEROLOGY (2017)
Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia
Felicia C. Goldstein et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan
Shu-Yu Tai et al.
PLOS ONE (2017)
No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease
Heidi Taipale et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Risk factors for dementia diagnosis in German primary care practices
Anke Booker et al.
INTERNATIONAL PSYCHOGERIATRICS (2016)
Confounding by Indication in Clinical Research
Demetrios N. Kyriacou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Association of Proton Pump Inhibitors With Risk of Dementia A Pharmacoepidemiological Claims Data Analysis
Willy Gomm et al.
JAMA NEUROLOGY (2016)
Risk of dementia in elderly patients with the use of proton pump inhibitors
Britta Haenisch et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12 Deficiency
Jameson R. Lam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
Nahuai Badiola et al.
PLOS ONE (2013)
Cognitive Function in an Elderly Population: Interaction Between Vitamin B-12 Status, Depression, and Apolipoprotein E epsilon(4): The Hordaland Homocysteine Study
Anna Vogiatzoglou et al.
PSYCHOSOMATIC MEDICINE (2013)
Histamine-2 Receptor Antagonist Use and Incident Dementia in an Older Cohort
Shelly L. Gray et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
Pharmacological management of GERD: where does it stand now?
Tiberiu Hershcovici et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations
Peter C. Austin
BIOMETRICAL JOURNAL (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Epidemiology of gastrooesophageal reflux disease: A systematic review
J Dent et al.
GUT (2005)
Reduced incidence of AD with NSAID but not H2 receptor antagonists -: The Cache County Study
PP Zandi et al.
NEUROLOGY (2002)
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists - The Cache County Study
JC Anthony et al.
NEUROLOGY (2000)
The preclinical phase of Alzheimer disease -: A 22-year prospective study of the Framingham cohort
MF Elias et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
